Memory B Cells and Their Transcriptomic Profiles Associated with Belimumab Resistance in Systemic Lupus Erythematosus in the Maintenance Phase

Normalized count of RNA sequences from systemic lupus erythematosus patients treated with belimumab. Sample names starting with 'R_' indicate responders, while those ending with '_NR' indicate non-responders. '0M' represents before treatment, '3M' represents three months after treatment, and '6M' represents six months after treatment. The numeric ID, excluding the last two characters, represents individual patients.